What analyst predict for Avid Bioservices NASDAQ:CDMO ?
Avid Bioservices headquartered in Tustin, California, United States is reporting their earnings on 12/10/2018 after the bell. Street forecast for the quarter ending Oct 2018 is $-0.09.
According to stock market daily analyst this is Lower then same time previous year.Avid Bioservices, reported EPS for the same quarter last year was $-0.09.
About Avid Bioservices NASDAQ:CDMO
Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 25 years of experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes, Avid’s services include cGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The company also provides a variety of process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization. www.avidbio.com
|% Change from 52 Week Low|
|% Change from 52 Week High|